nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—appendage—muscle cancer	0.195	0.413	CbGeAlD
Tranexamic Acid—PLG—embryo—muscle cancer	0.0648	0.137	CbGeAlD
Tranexamic Acid—PLG—smooth muscle tissue—muscle cancer	0.0509	0.108	CbGeAlD
Tranexamic Acid—PLG—renal system—muscle cancer	0.049	0.104	CbGeAlD
Tranexamic Acid—PLG—head—muscle cancer	0.0328	0.0695	CbGeAlD
Tranexamic Acid—PLG—testis—muscle cancer	0.0317	0.0671	CbGeAlD
Tranexamic Acid—Cerebral thrombosis—Methotrexate—muscle cancer	0.0312	0.0613	CcSEcCtD
Tranexamic Acid—Hemiparesis—Methotrexate—muscle cancer	0.0187	0.0367	CcSEcCtD
Tranexamic Acid—Cardiogenic shock—Doxorubicin—muscle cancer	0.0161	0.0318	CcSEcCtD
Tranexamic Acid—SLC15A2—renal system—muscle cancer	0.0157	0.0332	CbGeAlD
Tranexamic Acid—Thromboembolic event—Methotrexate—muscle cancer	0.0145	0.0285	CcSEcCtD
Tranexamic Acid—SLC15A2—vagina—muscle cancer	0.0114	0.0241	CbGeAlD
Tranexamic Acid—SLC15A2—head—muscle cancer	0.0105	0.0222	CbGeAlD
Tranexamic Acid—SLC15A2—testis—muscle cancer	0.0101	0.0215	CbGeAlD
Tranexamic Acid—Respiratory failure—Vincristine—muscle cancer	0.0082	0.0161	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Vincristine—muscle cancer	0.00815	0.016	CcSEcCtD
Tranexamic Acid—Cardiovascular disorder—Etoposide—muscle cancer	0.00743	0.0146	CcSEcCtD
Tranexamic Acid—Polyuria—Vincristine—muscle cancer	0.00666	0.0131	CcSEcCtD
Tranexamic Acid—Deep vein thrombosis—Methotrexate—muscle cancer	0.00642	0.0126	CcSEcCtD
Tranexamic Acid—Venous thrombosis—Doxorubicin—muscle cancer	0.00627	0.0123	CcSEcCtD
Tranexamic Acid—Embolism—Methotrexate—muscle cancer	0.00609	0.012	CcSEcCtD
Tranexamic Acid—Swelling—Etoposide—muscle cancer	0.00537	0.0106	CcSEcCtD
Tranexamic Acid—Embolism—Doxorubicin—muscle cancer	0.00527	0.0104	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Etoposide—muscle cancer	0.00489	0.00963	CcSEcCtD
Tranexamic Acid—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.00457	0.00899	CcSEcCtD
Tranexamic Acid—Dermatitis atopic—Doxorubicin—muscle cancer	0.00457	0.00899	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Vincristine—muscle cancer	0.00444	0.00874	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Vincristine—muscle cancer	0.00442	0.00869	CcSEcCtD
Tranexamic Acid—Cramp muscle—Etoposide—muscle cancer	0.00427	0.00839	CcSEcCtD
Tranexamic Acid—Flushing—Dactinomycin—muscle cancer	0.0042	0.00826	CcSEcCtD
Tranexamic Acid—Respiratory failure—Methotrexate—muscle cancer	0.00398	0.00783	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Methotrexate—muscle cancer	0.00391	0.00769	CcSEcCtD
Tranexamic Acid—Cardiovascular disorder—Doxorubicin—muscle cancer	0.00385	0.00758	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Vincristine—muscle cancer	0.00375	0.00738	CcSEcCtD
Tranexamic Acid—Angiopathy—Vincristine—muscle cancer	0.00367	0.00722	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Dactinomycin—muscle cancer	0.00366	0.00719	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Vincristine—muscle cancer	0.00365	0.00717	CcSEcCtD
Tranexamic Acid—Anaemia—Dactinomycin—muscle cancer	0.00364	0.00716	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Etoposide—muscle cancer	0.0036	0.00708	CcSEcCtD
Tranexamic Acid—Renal failure—Etoposide—muscle cancer	0.00359	0.00706	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Etoposide—muscle cancer	0.00358	0.00704	CcSEcCtD
Tranexamic Acid—Malaise—Dactinomycin—muscle cancer	0.00355	0.00699	CcSEcCtD
Tranexamic Acid—Atrioventricular block—Doxorubicin—muscle cancer	0.00349	0.00686	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Methotrexate—muscle cancer	0.00348	0.00684	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00343	0.00674	CcSEcCtD
Tranexamic Acid—Back pain—Vincristine—muscle cancer	0.00341	0.0067	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Doxorubicin—muscle cancer	0.00338	0.00666	CcSEcCtD
Tranexamic Acid—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00338	0.00666	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—muscle cancer	0.00337	0.171	CbGpPWpGaD
Tranexamic Acid—Myalgia—Dactinomycin—muscle cancer	0.00336	0.0066	CcSEcCtD
Tranexamic Acid—Discomfort—Dactinomycin—muscle cancer	0.00332	0.00652	CcSEcCtD
Tranexamic Acid—PLG—Regulation of IGF Activity by IGFBP—IGF2—muscle cancer	0.00328	0.167	CbGpPWpGaD
Tranexamic Acid—Anaemia—Vincristine—muscle cancer	0.00325	0.0064	CcSEcCtD
Tranexamic Acid—Polyuria—Methotrexate—muscle cancer	0.00323	0.00635	CcSEcCtD
Tranexamic Acid—Eye disorder—Etoposide—muscle cancer	0.00306	0.00602	CcSEcCtD
Tranexamic Acid—Convulsion—Vincristine—muscle cancer	0.00305	0.006	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Etoposide—muscle cancer	0.00304	0.00598	CcSEcCtD
Tranexamic Acid—Flushing—Etoposide—muscle cancer	0.00304	0.00598	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Doxorubicin—muscle cancer	0.00301	0.00592	CcSEcCtD
Tranexamic Acid—Myalgia—Vincristine—muscle cancer	0.003	0.0059	CcSEcCtD
Tranexamic Acid—Visual disturbance—Methotrexate—muscle cancer	0.00299	0.00589	CcSEcCtD
Tranexamic Acid—Angiopathy—Etoposide—muscle cancer	0.00297	0.00585	CcSEcCtD
Tranexamic Acid—Immune system disorder—Etoposide—muscle cancer	0.00296	0.00582	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Etoposide—muscle cancer	0.00295	0.00581	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00293	0.00577	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00293	0.00576	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Methotrexate—muscle cancer	0.0029	0.00569	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Vincristine—muscle cancer	0.00287	0.00565	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Vincristine—muscle cancer	0.00282	0.00554	CcSEcCtD
Tranexamic Acid—Fatigue—Dactinomycin—muscle cancer	0.00277	0.00545	CcSEcCtD
Tranexamic Acid—Back pain—Etoposide—muscle cancer	0.00276	0.00543	CcSEcCtD
Tranexamic Acid—Muscle spasms—Etoposide—muscle cancer	0.00274	0.00539	CcSEcCtD
Tranexamic Acid—Hypotension—Vincristine—muscle cancer	0.00269	0.00528	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Dactinomycin—muscle cancer	0.00265	0.00521	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Etoposide—muscle cancer	0.00265	0.00521	CcSEcCtD
Tranexamic Acid—Anaemia—Etoposide—muscle cancer	0.00264	0.00519	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00263	0.00517	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00262	0.00515	CcSEcCtD
Tranexamic Acid—Malaise—Etoposide—muscle cancer	0.00257	0.00506	CcSEcCtD
Tranexamic Acid—Abdominal pain—Dactinomycin—muscle cancer	0.00254	0.005	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00254	0.00499	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Etoposide—muscle cancer	0.00251	0.00493	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00251	0.00493	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Vincristine—muscle cancer	0.00248	0.00488	CcSEcCtD
Tranexamic Acid—Fatigue—Vincristine—muscle cancer	0.00248	0.00487	CcSEcCtD
Tranexamic Acid—Convulsion—Etoposide—muscle cancer	0.00247	0.00486	CcSEcCtD
Tranexamic Acid—Chest pain—Etoposide—muscle cancer	0.00243	0.00478	CcSEcCtD
Tranexamic Acid—Migraine—Doxorubicin—muscle cancer	0.00242	0.00476	CcSEcCtD
Tranexamic Acid—Discomfort—Etoposide—muscle cancer	0.0024	0.00472	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Dactinomycin—muscle cancer	0.00237	0.00466	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Methotrexate—muscle cancer	0.00235	0.00462	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Vincristine—muscle cancer	0.00235	0.00462	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Etoposide—muscle cancer	0.00233	0.00458	CcSEcCtD
Tranexamic Acid—Asthenia—Dactinomycin—muscle cancer	0.00231	0.00454	CcSEcCtD
Tranexamic Acid—Abdominal pain—Vincristine—muscle cancer	0.00227	0.00447	CcSEcCtD
Tranexamic Acid—Diarrhoea—Dactinomycin—muscle cancer	0.0022	0.00433	CcSEcCtD
Tranexamic Acid—Hypotension—Etoposide—muscle cancer	0.00218	0.00428	CcSEcCtD
Tranexamic Acid—Renal failure—Methotrexate—muscle cancer	0.00215	0.00423	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Vincristine—muscle cancer	0.00212	0.00416	CcSEcCtD
Tranexamic Acid—Dyspnoea—Etoposide—muscle cancer	0.00208	0.00408	CcSEcCtD
Tranexamic Acid—Angina pectoris—Doxorubicin—muscle cancer	0.00207	0.00407	CcSEcCtD
Tranexamic Acid—Asthenia—Vincristine—muscle cancer	0.00206	0.00406	CcSEcCtD
Tranexamic Acid—Vomiting—Dactinomycin—muscle cancer	0.00205	0.00402	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Etoposide—muscle cancer	0.00201	0.00395	CcSEcCtD
Tranexamic Acid—Fatigue—Etoposide—muscle cancer	0.00201	0.00395	CcSEcCtD
Tranexamic Acid—Haemoglobin—Methotrexate—muscle cancer	0.00197	0.00388	CcSEcCtD
Tranexamic Acid—Diarrhoea—Vincristine—muscle cancer	0.00197	0.00387	CcSEcCtD
Tranexamic Acid—Haemorrhage—Methotrexate—muscle cancer	0.00196	0.00386	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Etoposide—muscle cancer	0.00192	0.00377	CcSEcCtD
Tranexamic Acid—Nausea—Dactinomycin—muscle cancer	0.00191	0.00376	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Etoposide—muscle cancer	0.0019	0.00374	CcSEcCtD
Tranexamic Acid—Dizziness—Vincristine—muscle cancer	0.0019	0.00374	CcSEcCtD
Tranexamic Acid—Visual impairment—Methotrexate—muscle cancer	0.00189	0.00372	CcSEcCtD
Tranexamic Acid—Renal failure—Doxorubicin—muscle cancer	0.00186	0.00366	CcSEcCtD
Tranexamic Acid—Abdominal pain—Etoposide—muscle cancer	0.00184	0.00362	CcSEcCtD
Tranexamic Acid—Eye disorder—Methotrexate—muscle cancer	0.00183	0.00361	CcSEcCtD
Tranexamic Acid—Vomiting—Vincristine—muscle cancer	0.00183	0.00359	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Methotrexate—muscle cancer	0.00182	0.00358	CcSEcCtD
Tranexamic Acid—Headache—Vincristine—muscle cancer	0.0018	0.00354	CcSEcCtD
Tranexamic Acid—Angiopathy—Methotrexate—muscle cancer	0.00178	0.0035	CcSEcCtD
Tranexamic Acid—Sinusitis—Doxorubicin—muscle cancer	0.00178	0.00349	CcSEcCtD
Tranexamic Acid—Immune system disorder—Methotrexate—muscle cancer	0.00177	0.00349	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Methotrexate—muscle cancer	0.00177	0.00348	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Etoposide—muscle cancer	0.00172	0.00337	CcSEcCtD
Tranexamic Acid—Haemoglobin—Doxorubicin—muscle cancer	0.00171	0.00336	CcSEcCtD
Tranexamic Acid—Nausea—Vincristine—muscle cancer	0.00171	0.00336	CcSEcCtD
Tranexamic Acid—Haemorrhage—Doxorubicin—muscle cancer	0.0017	0.00334	CcSEcCtD
Tranexamic Acid—Asthenia—Etoposide—muscle cancer	0.00167	0.00329	CcSEcCtD
Tranexamic Acid—Back pain—Methotrexate—muscle cancer	0.00165	0.00325	CcSEcCtD
Tranexamic Acid—Visual impairment—Doxorubicin—muscle cancer	0.00164	0.00322	CcSEcCtD
Tranexamic Acid—Diarrhoea—Etoposide—muscle cancer	0.00159	0.00313	CcSEcCtD
Tranexamic Acid—Eye disorder—Doxorubicin—muscle cancer	0.00159	0.00312	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Methotrexate—muscle cancer	0.00159	0.00312	CcSEcCtD
Tranexamic Acid—Anaemia—Methotrexate—muscle cancer	0.00158	0.00311	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Doxorubicin—muscle cancer	0.00158	0.0031	CcSEcCtD
Tranexamic Acid—Flushing—Doxorubicin—muscle cancer	0.00158	0.0031	CcSEcCtD
Tranexamic Acid—Angiopathy—Doxorubicin—muscle cancer	0.00154	0.00303	CcSEcCtD
Tranexamic Acid—Malaise—Methotrexate—muscle cancer	0.00154	0.00303	CcSEcCtD
Tranexamic Acid—Dizziness—Etoposide—muscle cancer	0.00154	0.00303	CcSEcCtD
Tranexamic Acid—Immune system disorder—Doxorubicin—muscle cancer	0.00154	0.00302	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Doxorubicin—muscle cancer	0.00153	0.00301	CcSEcCtD
Tranexamic Acid—Arrhythmia—Doxorubicin—muscle cancer	0.00152	0.00299	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—FOXO1—muscle cancer	0.00151	0.0766	CbGpPWpGaD
Tranexamic Acid—Convulsion—Methotrexate—muscle cancer	0.00148	0.00291	CcSEcCtD
Tranexamic Acid—Vomiting—Etoposide—muscle cancer	0.00148	0.00291	CcSEcCtD
Tranexamic Acid—Headache—Etoposide—muscle cancer	0.00146	0.00287	CcSEcCtD
Tranexamic Acid—Arthralgia—Methotrexate—muscle cancer	0.00145	0.00286	CcSEcCtD
Tranexamic Acid—Chest pain—Methotrexate—muscle cancer	0.00145	0.00286	CcSEcCtD
Tranexamic Acid—Myalgia—Methotrexate—muscle cancer	0.00145	0.00286	CcSEcCtD
Tranexamic Acid—Discomfort—Methotrexate—muscle cancer	0.00144	0.00283	CcSEcCtD
Tranexamic Acid—Back pain—Doxorubicin—muscle cancer	0.00143	0.00281	CcSEcCtD
Tranexamic Acid—Muscle spasms—Doxorubicin—muscle cancer	0.00142	0.0028	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Methotrexate—muscle cancer	0.00139	0.00274	CcSEcCtD
Tranexamic Acid—Nausea—Etoposide—muscle cancer	0.00138	0.00272	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Doxorubicin—muscle cancer	0.00137	0.0027	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Methotrexate—muscle cancer	0.00137	0.00269	CcSEcCtD
Tranexamic Acid—Anaemia—Doxorubicin—muscle cancer	0.00137	0.00269	CcSEcCtD
Tranexamic Acid—Malaise—Doxorubicin—muscle cancer	0.00133	0.00262	CcSEcCtD
Tranexamic Acid—Hypotension—Methotrexate—muscle cancer	0.0013	0.00256	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Doxorubicin—muscle cancer	0.0013	0.00256	CcSEcCtD
Tranexamic Acid—Convulsion—Doxorubicin—muscle cancer	0.00128	0.00252	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00127	0.0025	CcSEcCtD
Tranexamic Acid—Myalgia—Doxorubicin—muscle cancer	0.00126	0.00248	CcSEcCtD
Tranexamic Acid—Arthralgia—Doxorubicin—muscle cancer	0.00126	0.00248	CcSEcCtD
Tranexamic Acid—Chest pain—Doxorubicin—muscle cancer	0.00126	0.00248	CcSEcCtD
Tranexamic Acid—Discomfort—Doxorubicin—muscle cancer	0.00124	0.00245	CcSEcCtD
Tranexamic Acid—Dyspnoea—Methotrexate—muscle cancer	0.00124	0.00245	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—TIMM10—muscle cancer	0.00123	0.0625	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Methotrexate—muscle cancer	0.00123	0.00241	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Doxorubicin—muscle cancer	0.00121	0.00237	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Methotrexate—muscle cancer	0.0012	0.00237	CcSEcCtD
Tranexamic Acid—Fatigue—Methotrexate—muscle cancer	0.0012	0.00236	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Doxorubicin—muscle cancer	0.00118	0.00233	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Methotrexate—muscle cancer	0.00115	0.00226	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Methotrexate—muscle cancer	0.00114	0.00224	CcSEcCtD
Tranexamic Acid—Hypotension—Doxorubicin—muscle cancer	0.00113	0.00222	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—IGF2—muscle cancer	0.00112	0.0572	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Methotrexate—muscle cancer	0.0011	0.00217	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.0011	0.00216	CcSEcCtD
Tranexamic Acid—Dyspnoea—Doxorubicin—muscle cancer	0.00108	0.00212	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.00107	0.0545	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Doxorubicin—muscle cancer	0.00106	0.00209	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00104	0.00205	CcSEcCtD
Tranexamic Acid—Fatigue—Doxorubicin—muscle cancer	0.00104	0.00205	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Methotrexate—muscle cancer	0.00103	0.00202	CcSEcCtD
Tranexamic Acid—Asthenia—Methotrexate—muscle cancer	0.001	0.00197	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Doxorubicin—muscle cancer	0.000995	0.00196	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000987	0.00194	CcSEcCtD
Tranexamic Acid—Abdominal pain—Doxorubicin—muscle cancer	0.000954	0.00188	CcSEcCtD
Tranexamic Acid—Diarrhoea—Methotrexate—muscle cancer	0.000954	0.00188	CcSEcCtD
Tranexamic Acid—Dizziness—Methotrexate—muscle cancer	0.000922	0.00181	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—DMD—muscle cancer	0.000914	0.0465	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Doxorubicin—muscle cancer	0.00089	0.00175	CcSEcCtD
Tranexamic Acid—Vomiting—Methotrexate—muscle cancer	0.000887	0.00174	CcSEcCtD
Tranexamic Acid—Headache—Methotrexate—muscle cancer	0.000874	0.00172	CcSEcCtD
Tranexamic Acid—Asthenia—Doxorubicin—muscle cancer	0.000866	0.0017	CcSEcCtD
Tranexamic Acid—Nausea—Methotrexate—muscle cancer	0.000828	0.00163	CcSEcCtD
Tranexamic Acid—Diarrhoea—Doxorubicin—muscle cancer	0.000826	0.00162	CcSEcCtD
Tranexamic Acid—Dizziness—Doxorubicin—muscle cancer	0.000798	0.00157	CcSEcCtD
Tranexamic Acid—Vomiting—Doxorubicin—muscle cancer	0.000768	0.00151	CcSEcCtD
Tranexamic Acid—Headache—Doxorubicin—muscle cancer	0.000756	0.00149	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—FOXO4—muscle cancer	0.000726	0.0369	CbGpPWpGaD
Tranexamic Acid—Nausea—Doxorubicin—muscle cancer	0.000717	0.00141	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS2—muscle cancer	0.000554	0.0282	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FOXO1—muscle cancer	0.000536	0.0273	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ANGPT2—muscle cancer	0.000529	0.0269	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000499	0.0254	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—muscle cancer	0.000471	0.024	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	0.000449	0.0228	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TP53—muscle cancer	0.000415	0.0211	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KIT—muscle cancer	0.000408	0.0208	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—muscle cancer	0.000401	0.0204	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MDM2—muscle cancer	0.000322	0.0164	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KIDINS220—muscle cancer	0.000321	0.0163	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IGF2—muscle cancer	0.000257	0.0131	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000209	0.0106	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—IGF2—muscle cancer	0.000202	0.0103	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTCH1—muscle cancer	0.000126	0.00642	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FOXO4—muscle cancer	0.000109	0.00552	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFA—muscle cancer	0.000108	0.00548	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CNR1—muscle cancer	0.000107	0.00542	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF2—muscle cancer	8.71e-05	0.00443	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TP53—muscle cancer	8.14e-05	0.00414	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FOXO1—muscle cancer	8.02e-05	0.00408	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KIT—muscle cancer	6.11e-05	0.00311	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MDM2—muscle cancer	4.81e-05	0.00245	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—muscle cancer	3.65e-05	0.00186	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—muscle cancer	2.76e-05	0.0014	CbGpPWpGaD
